Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 991 | Environmental Toxicology and Pharmacology | 7.9 | Q1 | Elsevier | 81.0% 25/131 Toxicology | 6234 | 788 |
| 992 | Clinical Trials | 4.1 | Q1 | SAGE | 81.0% 124/668 General Medicine | 1202 | 292 |
| 993 | Investigational New Drugs | 6.9 | Q1 | Springer Nature | 80.0% 55/275 Pharmacology (medical) | 3368 | 485 |
| 994 | Expert Opinion on Biological Therapy | 7.6 | Q1 | Taylor & Francis | 80.0% 24/121 Clinical Biochemistry | 3607 | 475 |
| 995 | Pharmaceutical Research | 6.8 | Q1 | Springer Nature | 79.0% 57/275 Pharmacology (medical) | 5066 | 749 |
| 996 | Pharmacological Reports | 7.7 | Q1 | Springer Nature | 78.0% 70/321 Pharmacology | 3567 | 466 |
| 997 | Expert Opinion on Drug Metabolism and Toxicology | 7.2 | Q1 | Taylor & Francis | 78.0% 29/131 Toxicology | 2225 | 311 |
| 998 | Fitoterapia | 3.9 | Q1 | Elsevier | 78.0% 28/126 Horticulture | 4462 | 1138 |
| 999 | Current Drug Targets | 7.2 | Q1 | Bentham Science Publishers | 78.0% 27/121 Clinical Biochemistry | 2452 | 341 |
| 1000 | Expert Opinion on Therapeutic Targets | 7.2 | Q1 | Taylor & Francis | 78.0% 26/121 Clinical Biochemistry | 2223 | 309 |
| 1001 | Antiviral Research | 7.3 | Q1 | Elsevier | 76.0% 77/321 Pharmacology | 4971 | 680 |
| 1002 | Psychopharmacology | 7.3 | Q1 | Springer Nature | 76.0% 76/321 Pharmacology | 6752 | 922 |
| 1003 | International Immunopharmacology | 7.2 | Q1 | Elsevier | 75.0% 80/321 Pharmacology | 40864 | 5648 |
| 1004 | Drug Metabolism and Disposition | 6.8 | Q1 | Elsevier | 75.0% 45/185 Pharmaceutical Science | 3830 | 565 |
| 1005 | Reviews on Recent Clinical Trials | 3.4 | Q1 | Bentham Science Publishers | 75.0% 163/668 General Medicine | 470 | 138 |
| 1006 | Planta Medica | 4.5 | Q2 | Thieme | 74.0% 29/112 Complementary and Alternative Medicine | 1825 | 403 |
| 1007 | Personalized Medicine | 3.2 | Q2 | Taylor & Francis | 74.0% 172/668 General Medicine | 577 | 180 |
| 1008 | Current Vascular Pharmacology | 5.4 | Q2 | Bentham Science Publishers | 73.0% 105/397 Cardiology and Cardiovascular Medicine | 882 | 163 |
| 1009 | Cancer Chemotherapy and Pharmacology | 5.7 | Q2 | Springer Nature | 72.0% 76/275 Pharmacology (medical) | 2889 | 508 |
| 1010 | Journal of Cardiovascular Pharmacology | 5.3 | Q2 | Wolters Kluwer Health | 72.0% 109/397 Cardiology and Cardiovascular Medicine | 3118 | 587 |
| 1011 | Pharmaceutical Statistics | 3.2 | Q2 | John Wiley & Sons | 71.0% 85/293 Statistics and Probability | 1045 | 330 |
| 1012 | Drug Metabolism and Pharmacokinetics | 5.6 | Q2 | Japanese Society for the Study of Xenobiotics | 71.0% 79/275 Pharmacology (medical) | 1014 | 182 |
| 1013 | Clinical Therapeutics | 5.6 | Q2 | Elsevier | 71.0% 78/275 Pharmacology (medical) | 3560 | 638 |
| 1014 | Vascular Pharmacology | 6.4 | Q2 | Elsevier | 71.0% 55/190 Physiology | 1704 | 268 |
| 1015 | American Journal of Health-System Pharmacy | 2.6 | Q2 | Oxford University Press | 71.0% 14/47 Pharmacy | 3015 | 1138 |
| 1016 | European Journal of Clinical Pharmacology | 5.5 | Q2 | Springer Nature | 70.0% 81/275 Pharmacology (medical) | 3699 | 673 |
| 1017 | Toxicology and Applied Pharmacology | 6.4 | Q2 | Elsevier | 69.0% 99/321 Pharmacology | 6646 | 1046 |
| 1018 | Pharmaceutical Medicine | 5.5 | Q2 | Springer Nature | 69.0% 84/275 Pharmacology (medical) | 714 | 131 |
| 1019 | Journal of Pharmacy and Pharmacology | 6.1 | Q2 | Oxford University Press | 69.0% 57/185 Pharmaceutical Science | 3413 | 560 |
| 1020 | Journal of AOAC International | 4.2 | Q2 | AOAC International | 69.0% 128/414 Agronomy and Crop Science | 2994 | 718 |